Background/Aims: Adiponectin and its receptors, AdipoR1 and AdipoR2, constitute integral components of energy homeostatic mechanism in peripheral tissues. Recent studies have implicated adiponectin in central neural networks regulating food intake and energy expenditure. The present study aimed at investigating the possible expression and distribution of adiponectin and its receptors in human pituitary gland, hypothalamus and different brain areas. Methods: Sections of the pituitary gland, hypothalamus and adjacent basal forebrain area, cerebrum and cerebellum from 35 autopsy cases, were examined using HE, PAS-Orange G, luxol fast blue/cresyl violet stains and single and double immunohistochemistry using adiponectin, AdipoR1, AdipoR2, choline acetyltransferase, FSH, LH, TSH, GH, ACTH and prolactin-specific antibodies. Age and BMI mean values ± SD of the autopsy cases were 56 ± 18 years and 27 ± 5 kg/m2, respectively. Results: Strong adiponectin expression was observed in pituitary gland. In pars distalis (PD), adiponectin localized in GH, FSH, LH and TSH-producing cells and in pars tuberalis (PT) in FSH, LH and TSH-producing cells. Strong to moderate expression of AdipoR1 and AdipoR2 was observed in PD by the same cell types as adiponectin. No immunoreactivity for adiponectin receptors was noted in cells of PT. Intense AdipoR1 immunostaining was observed in neurons of lateral hypothalamic area and of nucleus basalis of Meynert (NBM). Conclusions: Adiponectin and its receptors expression in human pituitary might indicate the existence of a local system, modulating endocrine axes. Furthermore, the presence of AdipoR1 in hypothalamus and NBM suggests that adiponectin may participate in central neural signaling pathways controlling energy homeostasis and higher brain functions.

Keywords:
Adiponectin, Adiponectin receptors, Pituitary, Hypothalamus, Nucleus basalis of Meynert
1.
Grill HJ, Kaplan JM: The neuroanatomical axis for control of energy balance. Front Neuroendocrinol 2002;23:2–40.
2.
Berthoud HR: Multiple neural systems controlling food intake and body weight. Neurosci Bebehav Rev 2002;26:393–428.
3.
Bernardis LL, Bellinger LL: The lateral hypothalamic area revisited: neuroanatomy, body weight regulation, neuroendocrinology and metabolism. Neurosci Biobehav Rev 1993;17:141–193.
4.
Cerri M, Morrison SF: Activation of lateral hypothalamic neurons stimulates brown adipose tissue thermogenesis. Neuroscience 2005;135:627–638.
5.
Harris GC, Aston-Jones G: Arousal and reward: a dichotomy in orexin function. Trends Neurosci 2006;29:571–577.
6.
Arendt T, Bigl V, Tennstedt A, Arendt A: Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer’s disease. Neuroscience 1985;14:1–14.
7.
Rolls ET: The neurophysiology of feeding. Int J Obes 1984;8:139–150.
8.
Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I: An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003;163:1524–1528.
9.
Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J: Association of metabolic syndrome with Alzheimer disease. Neurology 2006;67:843–847.
10.
Kernshaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548–2556.
11.
Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762–769.
12.
Wynne K, Stanley S, McGowan B, Bloom S: Appetite control. J Endocrinol 2005;184:291–318.
13.
Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS: Adiponectin acts in the brain to decrease body weight. Nat Med 2004;10:524–529.
14.
Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T: Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007;6:55–68.
15.
Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tschop M, Banks WA: Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006;55:141–147.
16.
Pan W, Tu H, Kastin AJ: Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 2006;27:911–916.
17.
Kusminski C, McTernan P, Schraw T, Kos K, O’Hare J, Ahima R, et al: Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 2007;50:634–642.
18.
Kos K, Harte AL, da Silva NF, Tonchev A, Chaldakov G, James S, Snead DR, Hoggart B, O’Hare JP, McTernan PG, Kumar S: Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 2007;92:1129–1136.
19.
Neumeier M, Weigert J, Buettner R, Wanninger J, Schäffler A, Müller AM, Killian S, Sauerbruch S, Schlachetzki F, Steinbrecher A, Aslanidis C, Schölmerich J, Buechler C: Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol 2007;293:E965–E969.
20.
Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, Dieguez C, Gualillo O, Gonzalez-Juanatey JR, Lago F: Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 2005;579:5163–5169.
21.
Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM: Induction of adiponectin in skeletal muscle by inflammatory adipocytokines: in vivo and in vitro studies. Endocrinology 2004;145:5589–5597.
22.
Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE: Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004;35:842–849.
23.
Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena-Sempere M, Dieguez C, Castano JP, Malagon MM: Regulation of pituitary cell function by adiponectin. Endocrinology 2007;148:401–410.
24.
Caminos JE, Nogueiras R, Gallego R, Bravo S, Tovar S, García-Caballero T, Casanueva FF, Diéguez C: Expression and regulation of adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metab 2005;90:4276–4286.
25.
Maddineni S, Metzger S, Ocon O, Hendricks G 3rd, Ramachandran R: Adiponectin gene is expressed in multiple tissues in the chicken: food deprivation influences adiponectin messenger ribonucleic acid expression. Endocrinology 2005;146:4250–4256.
26.
Wilkinson M, Brown R, Imran SA, Ur E: Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 2007;86:191–209.
27.
Fry M, Smith PM, Hoyda TD, Duncan M, Ahima RS, Sharkey KA, Ferguson AV: Area postrema neurons are modulated by the adipocyte hormone adiponectin. J Neurosci 2006;26:9695–9702.
28.
Hoyda TD, Fry M, Ahima RS, Ferguson AV: Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus. J Physiol 2007;585:805–916.
29.
Oda Y, Nakanishi I: The distribution of cholinergic neurons in the human central nervous system. Histol Histopathol 2000;15:825–834.
30.
Yeung CM, Chan CB, Leung PS, Cheng CH: Cells of the anterior pituitary. Int J Biochem Cell Biol 2006;38:1441–1449.
31.
Jin L, Burguera BG, Couce ME, Scheithauer BW, Lamsan J, Eberhardt NL, Kulig E, Lloyd RV: Leptin and leptin receptor expression in normal and neoplastic pituitary: evidence of a regulatory role for leptin on pituitary cell proliferation. J Clin Endocrinol Metab 1999;84:2903–2911.
32.
Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB: The expression of GHSR ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:881–887.
33.
Lu M, Tang Q, Olefsky JM, Mellon PL, Webster NJ: Adiponectin activates AMPK and decreases luteinizing hormone secretion in LβT2 gonadotropes. Mol Endocrinol 2008;22:760–771.
34.
Pontikides N, Krassas GE: Basic endocrine products of adipose tissue in states of thyroid function. Thyroid 2007;17:421–431.
35.
Shinoda Y, Yamaguchi M, Ogata N, Akune T, Kubota N, Yamauchi T, Terauchi Y, Kadowaki T, Takeuchi Y, Fukumoto S, Ikeda T, Hoshi K, Chung UI, Nakamura K, Kawaguchi H: Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006;99:196–208.
36.
Morgan PJ, Williams LM: The pars tuberalis of the pituitary: a gateway for neuroendocrine output. Rev Reprod 1996;1:153–161.
37.
Wittkowski WH, Schulze-Bonhage AH, Bockers TM: The pars tuberalis of the hypophysis: a modulator of the pars distalis? Acta Endocrinol (Copenh) 1992;126:285–290.
38.
Bockmann J, Kreutz MR, Wittkowski W, Bockers TM: TSH expression in murine hypophyseal pars tuberalis-specific cells. Acta Anat (Basel) 1997;160:189–194.
39.
Boix-Trelis N, Vale-Martinez A, Guillazo-Blanch G, Costa-Miserachs D, Marti-Nicolovius M: Effects of nucleus basalis magnocellularis stimulation on a socially transmitted food preference and c-Fos expression. Learn Mem 2006;13:783–793.
40.
Wilson FAW, Rolls ET: Neuronal responses related to reinforcement in the primate basal forebrain. Brain Res 1990;509:213–231.
41.
Semba K: Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance. Behav Brain Res 2000;115:117–141.
42.
Swaab DF: Handbook of Clinical Neurology. The Human Hypothalamus: Basic and Clinical Aspects. I. Nuclei of the Human Hypothalamus. Amsterdam, Elsevier, 2003, vol 79, pp 39–59.
43.
Giordano V, Peluso G, Iannuccelli M, Benatti P, Nicolai R, Calvani M: Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer’s dementia. Neurochem Res 2007;32:555–567.
44.
Couce ME, Burguera B, Parisi JE, Jensen MD, Lloyd RV: Localization of leptin receptor in the human brain. Neuroendocrinology 1997;66:145–150.
45.
Bjursell M, Ahnmark A, Bohlooly YM, William-Olsson L, Rhedin M, Peng XR, Ploj K, Gerdin AK, Arnerup G, Elmgren A, Berg AL, Oscarsson J, Lindén D: Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 2007;56:583–593.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.